In confirmation hearings, HHS pick Becerra shines light on policy priorities
But will he merely “do the White House’s bidding”?
Policy
Why marketing and communication will play a crucial role in Biden’s extended ACA enrollment period
The extra three months represent an opportunity to persuade as well as to educate.
Biden wants equitable distribution of vaccines, but there’s a long way to go
State and local groups can – and should – be a large part of the bigger push.
The path ahead for the FDA
In a Coalition for Healthcare Communication webinar, former FDA exec Nancy Bradish Myers reflected on the agency’s tumultuous 2020 and charted a path forward for 2021.
Health Policy 2021: COVID-19 pandemic, drug pricing, ACA reform and data privacy
Ending the pandemic is clearly the top public-health priority for the incoming Biden administration. Will action on drug pricing, ACA reform and data privacy follow?
“It’s always interesting when there’s a new administration and a new political configuration”
Washington healthcare policy insider Terry Haines offers his thoughts on COVID relief, the future of the Affordable Care Act and more.
The MM+M Podcast 11.4.2020: Post-election analysis from a trio of healthcare policy pros
With election results hanging in the balance a day after the US election, three A-list policy pros explain what we can expect for healthcare under two very different presidential scenarios.
Numerous groups are attempting to diversify COVID vaccine research
With communities of color historically underrepresented in clinical trials, numerous groups are working to diversify COVID-19 vaccine research.
COVID-19 kicks drug pricing down the road
The attention to the upcoming presidential election also dims the likelihood of legislation efforts until 2021.
House committee to investigate how USPS slowdown affects prescriptions by mail
The House Energy and Commerce subcommittee on health began an investigation this week.
